SEC Form 4 · accession 0001578259-17-000014
ChronoScale Holdings Corp · CHRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russ Angold
Officer — President, Ekso Labs
Period of report
Apr 20, 2017
Accepted (ET)
Apr 24, 2017 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001549084
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.85 | Apr 20, 2017 | A | 15,000 | A | — | Apr 20, 2027 | Common Stock | 15,000 | 15,000 | D |
| Restricted Stock UnitsF2,F3 | — | Apr 20, 2017 | A | 7,000 | A | — | — | Common Stock | 7,000 | 7,000 | D |
Explanation of responses
- F1The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months.
- F2Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock.
- F3The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.